This paper discusses future directions for antiviral therapy in chronic hepatitis C, exploring potential new treatment strategies beyond current interferon-based approaches. The focus is on emerging therapeutic options that could improve outcomes for patients who do not respond to standard treatments.
Tanaka, Katsuaki